Canada's CareRx quarterly revenue slightly beats estimates on beds serviced growth

CareRx

05/03/2026 24:56

Overview

Canada pharmacy service provider's Q4 revenue slightly beat analyst expectations

Adjusted EBITDA for Q4 also beat expectations

Company commenced paying dividends and repurchased shares in 2025

Outlook

CareRx declares Q1 2026 dividend of C$0.02 per share payable April 9, 2026

Company aims to capture growth through home operator expansion plans

CareRx focuses on efficient scaling to drive future growth

Result Drivers

BED GROWTH - Increase in average beds serviced to 92,250 in Q4 2025 from 87,658 in Q4 2024 contributed to revenue growth

COST SAVINGS - Adjusted EBITDA margin improved due to cost savings initiatives

PLATFORM EXPANSION - Expanded platform with over 4,500 additional beds supports growth potential

Company press release: ID:nNFCD05mb

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Revenue
Slight Beat*
C$96.08 mln
C$95.27 mln (3 Analysts)
Q4 Net Income
C$23.79 mln
Q4 Adjusted EBITDA
Beat
C$8.81 mln
C$8.47 mln (3 Analysts)
Q4 Adjusted EBITDA Margin
9.20%
Q4 EBITDA
C$7.10 mln


*Applies to a deviation of less than 1%; not applicable for per-share numbers.

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)